Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Nasdaq futures fall after record Samsung profit fails to calm AI chip worries
- Oil gains after vessels attacked near Strait of Hormuz
- Citi says SpaceX stock has path to $900+ valuation. Here’s how
- Tesla stock target lifted at RBC on potential SpaceX merger
- Short squeezes more likely than widespread selling: Citi
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Insulet Corporation (PODD) PT Raised to $295 at Stifel
November 5, 2021 6:43 AM EDTStifel analyst Matthew Blackman raised the price target on Insulet Corporation (NASDAQ: PODD) to $295.00 (from $275.00) while maintaining a Hold rating.
The analyst commented, "PODD 3Q results were largely in-line with Consensus despite US Covid headwinds and intensifying OUS competitive pressures. WW Sales grew... More
Insulet (PODD) Misses Q3 EPS by 7c
November 4, 2021 4:47 PM EDTInsulet (NASDAQ: PODD) reported Q3 EPS of $0.18, $0.07 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $275.6 million versus the consensus estimate of $272.82 million.
2021 Outlook:
Revenue Guidance (in constant currency):For the year ending December 31, 2021,... More